SINGAPORE
- Media OutReach - 21 January 2019 - MIMS,
Asia's largest multi-channel provider of drug information, medical communications,
events management and marketing services, and Ashfield Healthcare
Communications, are pleased to announce the creation of a new global alliance.
Ashfield Healthcare Communications,
part of UDG Healthcare plc, provides global solutions for clients, adding value
by connecting insight, intelligence, and expertise to flawlessly execute
powerful, multichannel communication solutions. Ashfield Healthcare
Communications has a global network of 1,300 employees collaborating with more
than 100 pharma, biotech, device and nutraceutical companies.
For over 50 years, MIMS has been a
trusted medical knowledge source dedicated to empowering healthcare
professionals. MIMS' diverse expertise from data-driven marketing and events
management to scientific strategy and digital medication safety solutions.
Today MIMS is present in 16 markets across Asia Pacific with approximately two
million healthcare professional subscribing to its drug and resource portal,
digital and print publications, the only one of its kind in the region.
In light of an increasing trend
amongst pharmaceutical companies to conduct launches, scientific meetings and
marketing programs across multiple territories, Ashfield Healthcare
Communications and MIMS recognised the need for, and value of, establishing a
non-holding company approach to their current and future client relationships, complementing
each other's geographic reach and ultimately providing streamlined agility in
the delivery of their healthcare communications capabilities.
The synergy between MIMS and
Ashfield is the ability to take the compliance-based local knowledge within
these countries and execute global programs at the local level. Both are
capable of producing heavy-duty, highly scientific healthcare communications,
which will now reach across Asia, US, and Europe.
Ashfield Healthcare Communications
President Doug Burcin said: "I am delighted with the creation of this strategic
partnership. Ashfield Healthcare Communications operate in the US, Japan, and Europe
and now with MIMS we are able to extend our services throughout Asia Pacific. Together,
our alliance expands global and local delivery for Ashfield clients to an
additional 16 APAC countries and provides unprecedented expertise and
cross-collaboration of healthcare communications by both parties."
Victor Wright, Chief Client Officer
of pharma marketing for MIMS, said: "The partnership with Ashfield will form
the largest and most comprehensive high-science medical communications network
globally. The collaboration will provide us both with additional expertise and
territories, opening up fantastic opportunities to deliver the best for our
international pharmaceutical, biotech, and medical devices clients."
For more information on Ashfield
Healthcare Communications, visit www.ashfieldhealthcare.com and for MIMS, visit
http://corporate.mims.com or www.mimsmc.com for medical communications
services.
For further information and
interview opportunities with Ashfield, please contact Lara Lovenbury at
ramarketing I lara@ramarketingpr.com I 07972471903 I 0191 222 1242 I
www.ramarketingpr.com.
NOTES TO EDITOR
About MIMS
MIMS is Asia's largest
multi-channel provider of drug information, medical communications, events
management and marketing services. Established in 1963, our work empowers
healthcare professionals to improve patient outcomes by facilitating knowledge
exchange and better decision-making. Today, MIMS is present in 16 countries
across Asia Pacific with approximately two million healthcare professional
subscribers to our drug & resource portal, digital and print publications.
MIMS has offices in the following
markets:
Singapore (headquarters),
Australia, China, Hong Kong, Indonesia, India, Japan, Korea; Malaysia, Myanmar,
New Zealand, Philippines, Taiwan, Thailand, UAE, Vietnam
Visit http://corporate.mims.com to
learn more, and www.mimsmc.com for medical communications services.
About Ashfield Healthcare
Communications
Ashfield Healthcare Communications,
part of UDG Healthcare plc, provides global solutions for clients, adding value
through unique insights and tailored scientifically rigorous, multichannel,
healthcare communications offerings. Its mission is to improve lives by helping
healthcare professionals and patients get the medicines, knowledge, and support
they need. Ashfield Healthcare Communications' multichannel and specialist
agencies include ACUMED, Ashfield Digital & Creative, Ashfield Healthcare
Communications K.K., BlueMomentum, Cambridge BioMarketing, CircleScience,
Cirrus Communications, Clinical Bridges, CodonMedical, Create NYC, FireKite,
Galliard, Gardiner-Caldwell Communications, GeoMed, iMed Comms, Infusion,
MicroMass, Nyxeon, Pegasus, Physicians World Europe, QXV Comms, Scientific
Connexions, Seren Communications, StemScientific, Watermeadow Medical, and
Zoetic Science.
For more information, please go to
www.ashfieldhealthcarecommunications.com.
About Ashfield
Ashfield, part of UDG Healthcare
plc, is a global leader in commercialisation services for the healthcare
industry. We partner with our clients across Advisory, Healthcare
Communications, Commercial, Patient Solutions and Medical Affairs to build
creative, scalable and tailored health solutions that are executed flawlessly,
to deliver positive outcomes for patients and add value to your business. With
7,000 employees, the company operates in 25 countries, delivering services in
more than 50 countries across Europe, North America, South America and Asia. It
works with more than 250 businesses, including all of the world's top 25
pharmaceutical companies.
Its mission is to partner with its
clients, helping to improve lives by ensuring healthcare professionals and
patients get the medicines, knowledge and support they need.
Ashfield provides contract sales
teams, customer service reps, medical science liaison officers, remote
detailing, nurse educators, medical information, healthcare communications,
market access, market research, training, live and virtual events, digital,
creative, pharmacovigilance, audit and advisory services.
For more information, go to
www.ashfieldhealthcare.com.
http://www.media-outreach.com/release.php/View/7788#Contact